Close

Aurinia Pharmaceuticals (AUPH) Plans Single Phase III Clinical Trial for Voclosporin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. HCP


Go back to Aurinia Pharmaceuticals (AUPH) Plans Single Phase III Clinical Trial for Voclosporin
(NASDAQ: AUPH) Delayed: 5.03 -0.06 (1.18%)
Previous Close $5.09    52 Week High $5.69 
Open $5.09    52 Week Low $1.42 
Day High $5.16    P/E N/A 
Day Low $5.00    EPS $0.00 
Volume 786,047